Hakutulokset - David Nathanson
- Näytetään 1 - 20 yhteensä 26 tuloksesta
- Siirry seuraavalle sivulle
-
1
Insights into the mechanisms of lymph node metastasis Tekijä David Nathanson
Julkaistu 2003Revisão -
2
Economic burden associated with breast cancer recurrence Tekijä Lois Lamerato, Suzanne Havstad, Sanjay Gandhi, David Jones, David Nathanson
Julkaistu 2006Artigo -
3
Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes Tekijä David Nathanson, S., Leonard-Murali, Shravan, Burmeister, Charlotte, Susick, Laura, Baker, Patricia
Julkaistu 2020Teksti -
4
-
5
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality Tekijä Jan W. Eriksson, Johan Bodegård, David Nathanson, Marcus Thuresson, Thomas Nyström, Anna Norhammar
Julkaistu 2016Artigo -
6
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 200... Tekijä Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, Jan W. Eriksson, David Nathanson
Julkaistu 2016Artigo -
7
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and se... Tekijä Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson
Julkaistu 2016Artigo -
8
Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type... Tekijä Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson
Julkaistu 2017Artigo -
9
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study... Tekijä Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, David Nathanson, Jan W. Eriksson
Julkaistu 2019Artigo -
10
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety Tekijä David Nathanson, Bengt Ullman, Ulrika Löfström, Anders Hedman, Mats Frick, Åke Sjöholm, Thomas Nyström
Julkaistu 2012Artigo -
11
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive cont... Tekijä David Nathanson, Ann‐Marie Svensson, Mervete Miftaraj, Stefan Franzén, Jan Bolinder, Katarina Eeg‐Olofsson
Julkaistu 2021Artigo -
12
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study Tekijä Henrik Falhammar, Jonatan D. Lindh, Jan Calissendorff, Shermineh Farmand, Jakob Skov, David Nathanson, Buster Mannheimer
Julkaistu 2018Artigo -
13
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks i... Tekijä Viveca Ritsinger, Johan Bodegård, Robin Kristófi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan W. Eriksson, Anna Norhammar
Julkaistu 2023Artigo -
14
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study Tekijä Robin Kristófi, Johan Bodegård, Anna Norhammar, Marcus Thuresson, David Nathanson, Thomas Nyström, Kåre I. Birkeland, Jan W. Eriksson
Julkaistu 2021Artigo -
15
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization Tekijä Vladimer Darsalia, Sansan Hua, Martin Larsson, Carina Mallard, David Nathanson, Thomas Nyström, Åke Sjöholm, Maria E. Johansson, Cesare Patrone
Julkaistu 2014Artigo -
16
-
17
-
18
An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis Tekijä Gabi Tarcic, Shlomit Boguslavsky, Jean Wakim, Tai Kiuchi, A.H. Liu, Felicia Reinitz, David Nathanson, Takamune Takahashi, Paul S. Mischel, Tony Ng, Yosef Yarden
Julkaistu 2009Artigo -
19
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin Tekijä Grażyna Lietzau, William Davidsson, Claes‐Göran Östenson, Fausto Chiazza, David Nathanson, Hiranya Pintana, Josefin Skogsberg, Thomas Klein, Thomas Nyström, Vladimer Darsalia, Cesare Patrone
Julkaistu 2018Artigo -
20
Mechanisms of breast cancer metastasis Tekijä David Nathanson, Michael Detmar, Timothy P. Padera, Lucy Yates, Danny R. Welch, Thomas C. Beadnell, Adam D. Scheid, Emma D. Wrenn, Kevin J. Cheung
Julkaistu 2021Revisão
Työkalut:
Liittyvät aiheet
Medicine
Internal medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Cancer
Breast cancer
Population
Biology
Cancer research
Confidence interval
Disease
Engineering
Environmental health
Mechanical engineering
Stroke (engine)
Cohort
Hazard ratio
Pathology
Proportional hazards model
Dapagliflozin
Gene
Genetics
Insulin
Metastasis
Myocardial infarction
Oncology
Pediatrics
Pharmacology
Receptor